Physician-assisted death: A Canada-wide survey of ALS health care providers.

TitlePhysician-assisted death: A Canada-wide survey of ALS health care providers.
Publication TypeJournal Article
Year of Publication2016
AuteursAbrahao, A, Downar, J, Pinto, H, Dupré, N, Izenberg, A, Kingston, W, Korngut, L, O'Connell, C, Petrescu, N, Shoesmith, C, Tandon, A, Vargas-Santos, ABeatriz, Zinman, L
JournalNeurology
Volume87
Issue11
Pagination1152-60
Date Published2016 Sep 13
ISSN1526-632X
KeywordsAcademic Medical Centers, Adult, Amyotrophic Lateral Sclerosis, Attitude of Health Personnel, Canada, Cross-Sectional Studies, Female, Health Care Surveys, Humans, Male, Middle Aged, Physicians, Religion, Suicide, Assisted
Abstract

OBJECTIVE: To survey amyotrophic lateral sclerosis (ALS) health care providers to determine attitudes regarding physician-assisted death (PAD) after the Supreme Court of Canada (SCC) invalidated the Criminal Code provisions that prohibit PAD in February 2015.METHODS: We conducted a Canada-wide survey of physicians and allied health professionals (AHP) involved in the care of patients with ALS on their opinions regarding (1) the SCC ruling, (2) their willingness to participate in PAD, and (3) the PAD implementation process for patients with ALS.RESULTS: We received 231 responses from ALS health care providers representing all 15 academic ALS centers in Canada, with an overall response rate for invited participants of 74%. The majority of physicians and AHP agreed with the SCC ruling and believed that patients with moderate and severe stage ALS should have access to PAD; however, most physicians would not provide a lethal prescription or injection to an eligible patient. They preferred the patient obtain a second opinion to confirm eligibility, have a psychiatric assessment, and then be referred to a third party to administer PAD. The majority of respondents felt unprepared for the initiation of this program and favored the development of PAD training modules and guidelines.CONCLUSIONS: ALS health care providers support the SCC decision and the majority believe PAD should be available to patients with moderate to severe ALS with physical or emotional suffering. However, few clinicians are willing to directly provide PAD and additional training and guidelines are required before implementation in Canada.

DOI10.1212/WNL.0000000000002786
Alternate JournalNeurology
PubMed ID27178703
PubMed Central IDPMC5027804